Beta Bionics, Inc. SEC filings BBNX

Beta Bionics, Inc. has 285 filings in SEC EDGAR's recent list, going back to May 16, 2016. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.

Beta Bionics, Inc. SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 5, 2026 —
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Oct 29, 2026 Oct 27, 2026
4 Insider transaction Oct 28, 2026 Oct 26, 2026
10-Q Quarterly report Oct 27, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 27, 2026 Oct 27, 2026
4 Insider transaction Oct 16, 2026 Oct 14, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 7, 2026 —
4 Insider transaction Oct 5, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 23, 2026 Sep 22, 2026
144 Notice of proposed sale Sep 22, 2026 —
4/A Filing Sep 18, 2026 Sep 9, 2026
4 Insider transaction Sep 17, 2026 Sep 16, 2026
4 Insider transaction Sep 17, 2026 Sep 16, 2026
8-K Current report
Other events
Sep 17, 2026 Sep 15, 2026
424B5 Prospectus supplement Sep 17, 2026 —
144 Notice of proposed sale Sep 16, 2026 —
144 Notice of proposed sale Sep 16, 2026 —
FWP Free writing prospectus Sep 16, 2026 —
424B5 Prospectus supplement Sep 16, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 15, 2026 Sep 14, 2026
4 Insider transaction Sep 15, 2026 Sep 14, 2026
4 Insider transaction Sep 10, 2026 Sep 9, 2026
144 Notice of proposed sale Sep 9, 2026 —
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 24, 2026 —
4/A Filing Jul 2, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
144 Notice of proposed sale Jun 4, 2026 —
144 Notice of proposed sale Jun 4, 2026 —
4 Insider transaction Jun 3, 2026 Jun 2, 2026
4 Insider transaction Jun 3, 2026 Jun 2, 2026
4 Insider transaction Jun 3, 2026 Jun 2, 2026
4 Insider transaction Jun 3, 2026 Jun 2, 2026
4 Insider transaction Jun 3, 2026 Jun 2, 2026
144 Notice of proposed sale Jun 3, 2026 —
144 Notice of proposed sale Jun 3, 2026 —
144 Notice of proposed sale Jun 3, 2026 —
144 Notice of proposed sale Jun 3, 2026 —
144 Notice of proposed sale Jun 3, 2026 —
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
8-K Current report
Shareholder vote results
May 22, 2026 May 21, 2026
144 Notice of proposed sale May 21, 2026 —
144 Notice of proposed sale May 21, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 21, 2026 May 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2026 —
10-Q Quarterly report Apr 21, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 21, 2026 Apr 21, 2026
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 10, 2026 —
DEF 14A Proxy statement Apr 10, 2026 May 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 16, 2026 Dec 2, 2025
4 Insider transaction Mar 16, 2026 Dec 2, 2025
4/A Filing Mar 13, 2026 Feb 27, 2026
4/A Filing Mar 13, 2026 Feb 27, 2026
4/A Filing Mar 13, 2026 Feb 27, 2026
4/A Filing Mar 13, 2026 Feb 27, 2026
4/A Filing Mar 13, 2026 Feb 27, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
S-3ASR Automatic shelf registration Feb 24, 2026 —
S-8 Employee stock plan registration Feb 24, 2026 —
10-K Annual report Feb 24, 2026 Dec 31, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 23, 2026 —
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 9, 2026 —
8-K Current report
Other events
Jan 30, 2026 Jan 29, 2026
4 Insider transaction Jan 14, 2026 Jan 13, 2026
4 Insider transaction Jan 14, 2026 Jan 13, 2026
4 Insider transaction Jan 14, 2026 Jan 13, 2026
4 Insider transaction Jan 14, 2026 Jan 13, 2026
4 Insider transaction Jan 14, 2026 Jan 13, 2026
4 Insider transaction Jan 14, 2026 Jan 13, 2026
8-K Current report
Results of operations
Jan 8, 2026 Jan 8, 2026
4 Insider transaction Jan 7, 2026 Jan 6, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
144/A Filing Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Dec 4, 2025 —
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 4, 2025 —
144 Notice of proposed sale Dec 4, 2025 —
144 Notice of proposed sale Dec 4, 2025 —
4 Insider transaction Dec 2, 2025 Dec 1, 2025
4 Insider transaction Dec 2, 2025 Dec 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
4 Insider transaction Nov 5, 2025 Oct 31, 2025
4 Insider transaction Nov 5, 2025 Oct 31, 2025
144 Notice of proposed sale Oct 31, 2025 —
144 Notice of proposed sale Oct 31, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 16, 2025 —
4 Insider transaction Oct 7, 2025 Oct 3, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 3, 2025 —
144 Notice of proposed sale Oct 1, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 19, 2025 —
4 Insider transaction Sep 9, 2025 Sep 8, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
4 Insider transaction Sep 8, 2025 Sep 5, 2025
144 Notice of proposed sale Sep 8, 2025 —
144 Notice of proposed sale Sep 5, 2025 —
144 Notice of proposed sale Sep 5, 2025 —
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 4, 2025 —
4 Insider transaction Aug 26, 2025 Aug 22, 2025
144 Notice of proposed sale Aug 22, 2025 —
4 Insider transaction Aug 20, 2025 Aug 19, 2025
4 Insider transaction Aug 20, 2025 Aug 19, 2025
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2025 —
10-Q Quarterly report Jul 29, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 29, 2025 Jul 29, 2025
8-K Current report
Regulation FD disclosure
Jun 23, 2025 Jun 22, 2025
144 Notice of proposed sale Jun 9, 2025 —
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
SCHEDULE 13G Ownership over 5% (passive) May 2, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Apr 9, 2025 —
10-K/A Amended annual report Mar 28, 2025 Dec 31, 2024
4 Insider transaction Mar 27, 2025 Mar 26, 2025
3 Initial insider ownership Mar 27, 2025 Mar 26, 2025
8-K Current report
Officer or director change
Mar 27, 2025 Mar 26, 2025
10-K Annual report Mar 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 25, 2025 Mar 25, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
BBNX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1674632
Former names
Beta Bionics, Inc (until Jan 6, 2025)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.